PubMed · 1993 · 88 citations · 0 references
MedicineCancer BiologyOncologyMolecular OncologySignal TransductionTumor ProgressionCancer Cell SignalingCancer ProgressionGrowth Factor SignalingNeoplastic TransformationOncogenic Signaling PathwaysSignal Transduction In CancerGrowth Factor Receptor ActivationGrowth FactorsTherapeutic Resistance MechanismsTransforming Growth Factor Beta Receptor SignalingTransforming Growth Factor Beta ReceptorsTransforming Growth Factor Beta RegulationTransforming Growth Factor Beta Signaling DisruptionTransforming Growth Factor-beta Signaling
Members of the transforming growth factor-beta family, especially transforming growth factor-beta type 1, are among the most potent growth-inhibitory factors for epithelial, lymphohematopoietic, and neuroectodermal cells. Resistance to transforming growth factor-beta-mediated growth inhibition is frequently observed in cancers derived from these cell types. We review two important aspects of cancer cell resistance to transforming growth factor-beta: 1) It occurs progressively during the multistep process of tumor progression, and 2) it may encompass a potentially wide range of mechanisms involving transforming growth factor-beta-receptor alterations and cell-signaling defects. Stepwise increases in resistance to the growth-inhibitory action of transforming growth factor-beta may therefore sometimes be attributed to not one but several defects that are involved in transforming growth factor-beta activation, binding, and signaling. These factors accumulate within expanding tumor subclones during disease progression.